drugset / Trial / NCT01554826
Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)
RandomizedParallel-groupTriple-blindPrevention
Summary
The clinical trial was designed to evaluate the immunogenicity and safety against pediatric Inactivated influenza vaccine (Split Virion) (0.25ml formulation) of Hualan administered on infants age 6 months to 36 months.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-05
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Split Vaccine | Vaccine | 0.25 ml | — |
| Comparator | Influenza Virus Vaccine | Vaccine | 0.25 ml | — |